Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
By Drug Type, Liraglutide Segment Accounts for 35.5% Market Share The liraglutide segment is projected to account for 35.5% of the GLP-1 diabetes treatment drugs market in 2025, reaffirming its position as the leading drug type category
Journal of Nutrition and Metabolism, 2018, 1729653
A 2025 Laryngoscope review described GLP-1s as a valuable tool for optimizing surgical patients bringing BMI down, reducing airway fat deposition, and improving surgical candidacy
What Cardinal Health is known for
Reach your health and fitness goals with clean ingredients and transparent labels, so you know exactly what you're putting in your body
US$ 20.14
US$ 29.83
US$ 25.38
US$ 25.23
